|
| |
ReProtect Inc. Pages on BioPortfolio:
BioPortfolio - ReProtect Inc.
ReProtect Inc. - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/29177-ReProtect_Inc...
|
BioPortfolio - ReProtect
View the current ReProtect Inc. Page on BioPortfolio.com . ... ReProtect Inc Print preview Print preview. General Information. Location. Region . Country.
...
http://www.bioportfolio.com/search/ReProtect.html...
|
BioPortfolio - BioPortfolio - ReProtect Inc.
BioPortfolio - ReProtect Inc. - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/29177/www.r...
|
BioPortfolio - ReProtect Inc. - Profile
ReProtect's goal is to provide safe, reliable and effective. prophylactic contraception . BioNews Results for ReProtect Inc. ...
http://www.bioportfolio.com/biocorporate/29177-ReProtect+Inc...
|
BioPortfolio - Biocorporate Search
ReProtect Inc. ReProtect's Mission is to reduce unwanted pregnancies and sexually transmitted diseases (STDs), including HIV/AIDS, by providing the most
...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...
|
BioPortfolio - carbomer inc
BioPortfolio - carbomer inc. Carbomer 974 Lubrizol Corporation 29400 Lakeland Boulevard Wickliffe, OH 44092 BufferGel ReProtect, Inc. 703 Stags Head Road .
...
http://www.bioportfolio.com/search/carbomer__inc.html...
|
BioPortfolio - HealthPaths Incorporated
Thomas Moench, President, ReProtect, Inc. * Shannon Cali, Senior Program Associate, Program for Appropriate Technology in Health (PATH) . ...
http://www.bioportfolio.com/search/HealthPaths_Incorporated....
|
BioPortfolio.com - BioWeb NORFLOXACIN NORFLOXACIN alaninyl ...
SOLVO Biotechnology, Inc. - Specialist in the field of multidrug ... Reliant Pharmaceuticals Repligen ReProtect Restoragen Ribozyme Pharmaceuticals Roche ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...
|
Results from other life science and pharmaceutical sites:
BioCentury - ReProtect Inc - Company Profile
ReProtect Inc Print preview ... and The Clear Route to ROI™ are trademarks of BioCentury Publications, Inc., P.O. Box 1246 San Carlos, CA 94070. ...
http://www.biocentury.com/companies/ReProtect_Inc?utm_source...
|
BioPortfolio - ReProtect Inc.
ReProtect Inc. - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/29177-ReProtect_Inc...
|
AIDSinfo - HIV/AIDS Drug Information - Carbomer 974
23 Dec 2008 ... Manufacturer Information. Carbomer 974. Lubrizol Corporation 29400 Lakeland Boulevard Wickliffe, OH 44092 BufferGel ReProtect, Inc. ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailT.aspx?int_id...
|
BioPortfolio - BioPortfolio - ReProtect Inc.
BioPortfolio - ReProtect Inc. - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/29177/www.r...
|
Carbomer 974 Carbomer 974
ReProtect, Inc. - Manufacturer contact, February 26, 2007. 3. ReProtect, Inc. - Business: ... ReProtect, Inc. - Science: Contraceptive Trial Successful. ...
http://www.aidsinfo.nih.gov/DrugsNew/pdfdrug_tech.asp?int_id...
|
Global Health Council - Cervical Barrier Methods
19 Jun 2006 ... Thomas Moench, President, ReProtect, Inc. * Shannon Cali, Senior Program Associate, Program for Appropriate Technology in Health (PATH) ...
http://www.globalhealth.org/news/article/7575...
|
Low pH immobilizes and kills human leukocytes and prevents ...
Two microbicides (BufferGel®(ReProtect, Inc., Baltimore, MD) [19-21] and Acidform (TOPCAD, Chicago, IL) [22]), have been developed with the goal of ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=12...
|
BioPortfolio - Biocorporate Search
ReProtect Inc. ReProtect's Mission is to reduce unwanted pregnancies and sexually transmitted diseases (STDs), including HIV/AIDS, by providing the most
...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...
|
Acid-Buffering Gel Microbicide Used With Diaphragm Is a Safe ...
11 Sep 2007 ... ReProtect, Inc, provided BufferGel, the acid-buffering gel microbicide. Johnson & Johnson provided Gynol II and OrthoFlex diaphragms. ...
http://www.medscape.com/viewarticle/562653...
|
1471-2334-5-79 1471-2334 Research article Low pH immobilizes and ...
Competing interests Cone and Moench are developers of BufferGel and Khanna is an employee of ReProtect Inc. All three hold equity in ReProtect, ...
http://www.biomedcentral.com/content/download/xml/1471-2334-...
|
|
